Medical News

RSS

New web-based tool examines community factors underlying COVID-19 outcomes

A new data visualization tool examines how and why COVID-19 impacts regions differently. Using daily updated data, COVIDMinder compares community risks, mediation tools, and outcomes related to COVID-19 by state across the United States, and by county within New York state.

13 Apr 2020

Columbia University launches CovidWatcher app to track virus spread in NYC

Researchers from Columbia University have launched CovidWatcher, an app that surveys users about their exposure to the new coronavirus, symptoms, access to medical care, and impact on daily life.

13 Apr 2020

Re-thinking the built environment to limit coronavirus transmission

The coronavirus disease (COVID-19) global pandemic has taken a toll on many countries across the globe. The hardest-hit countries are now grappling to contain the spread of various through social distancing measures, while others are now in total lockdown.

13 Apr 2020

Exercise enhances muscle-repair capabilities in old mice, Stanford study shows

A nightly jaunt on the exercise wheel enhances muscle-repair capabilities in old mice, according to a new study by researchers at Stanford School of Medicine.

13 Apr 2020

How does COVID-19 attack the body?

The coronavirus disease (COVID-19) attacks the lungs, leading to pneumonia, and eventually, a cascade of serious complications. But how does COVID-19 kill? Is it the virus itself or the result of the person’s immune system response?

13 Apr 2020

Novel coronavirus attacks and destroys T cells, just like HIV

The immune system has many components that work together in protecting the body from foreign invaders. One of the most important types of immune cells is T lymphocytes or T cells, a type of white blood cell that acts as the core of adaptive immunity, the system that modifies the immune response to specific pathogens.

13 Apr 2020

Extend lockdowns to stave off second wave of COVID-19

Social distancing, keeping people at home, and lockdowns are being implemented in many nations to prevent the spread of the highly infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Some countries that have seen declines in the number of new infections due to lockdowns are now looking to allow people to return to more normal daily routines.

13 Apr 2020

Cost of ‘repurposing’ existing drugs to treat COVID-19

The paper looks at repurposed drugs that might demonstrate efficacy against COVID-19, and if they could be manufactured profitably at very low costs to ensure affordable access to vital treatments for COVID-19 at low prices globally.

13 Apr 2020

Monitoring loss of smell could be key to COVID-19 detection

Researchers have found that persons who test positive for COVID-19 disease have common symptoms, including fever, cough, shortness of breath, and a temporary loss of the sense of smell.

13 Apr 2020

Missing COVID-19 antibodies suggest mystery immune response

Researchers at Shanghai Public Health Clinical Center have made important discoveries about the immune response among patients who have recovered from mild COVID-19 disease that could help to inform prevention and treatment methods, as well as improve the efficacy of community testing.

13 Apr 2020

RIT faculty receives NSF CAREER award to to study how human visual system perceives AR

A Rochester Institute of Technology faculty member received a prestigious National Science Foundation award to research how the human visual system perceives a mix of augmented reality and real-world content.

13 Apr 2020

WVU researchers develop viable alternatives to N95 masks

The novel coronavirus pandemic has nearly exhausted stockpiles of medical gear in the United States. Personal protective equipment, like masks, serve as a first-line defense for medical professionals with a front row seat to COVID-19.

13 Apr 2020

Sanders: In coronavirus relief effort, Congress fell short on paid sick leave

The pressure is building for Congress to pass a fourth coronavirus relief bill, beyond the roughly $2.2 trillion already approved to keep people and businesses viable during an unprecedented viral attack.

13 Apr 2020

UChicago Medicine launches clinical trial to explore plasma transfusions for COVID-19 patients

The University of Chicago Medicine is launching a clinical trial to study whether blood plasma from people who have recovered from COVID-19 can be used to treat patients who are still in the hospital with severe disease symptoms.

13 Apr 2020

Study looks into how malaria parasite evades the immune system

The parasite causing the most severe form of human malaria uses proteins to make red blood cells sticky, making it harder for the immune system to destroy it and leading to potentially fatal blood clots. New research at the Crick has identified how the parasite may control this process.

13 Apr 2020

FDA approves new Rutgers saliva test for coronavirus

The FDA has granted emergency use authorization to Rutgers' RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency.

13 Apr 2020

FDA approves first-ever treatment for patients with inoperable plexiform neurofibromas

The U.S. Food and Drug Administration has approved Koselugo (selumetinib) for use in patients with inoperable plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).

13 Apr 2020

Stanford scientists find gene variant that staves off Alzheimer's in some people

Stanford Medicine researchers have found a gene variant that protects carriers of another gene variant, ApoE4, from developing Alzheimer’s disease — the first demonstration of that beneficial effect.

13 Apr 2020

Milk allergy guidelines may be linked to overdiagnosis in babies and children

Current medical guidelines for diagnosing cow's milk allergy in babies and young children may be linked to overdiagnosis of the condition.

13 Apr 2020

Rockefeller and SNF announce $3 million expansion of partnership for COVID-19 research

The Rockefeller University and the Stavros Niarchos Foundation today announced a $3 million expansion of their longstanding partnership for research and medicine, bolstering Rockefeller's round-the-clock research initiatives related to COVID-19 and the SARS-CoV-2 virus that causes it.

13 Apr 2020